SlideShare a Scribd company logo
This document is confidential and contains proprietary information, including trade secrets of CitiusTech. Neither the document nor any of the information
contained in it may be reproduced or disclosed to any unauthorized person under any circumstances without the express written permission of CitiusTech.
Opioid Epidemic: Causes, Impact &
Future
January 2020| Author: Shiven Kalelkar; Sr. Healthcare Consultant
CitiusTech Thought
Leadership
2
Agenda
▪ Opioid Epidemic: Key Trends
▪ Opioid Epidemic: Measures for Controlling the Epidemic
▪ Opioid Epidemic: What Lies in the Future
▪ References
3
Opioid Epidemic: America’s Worst Drug Crisis Ever (1/2)
2011 2012 2015 2016 2017 2018
An estimated 10.3 million Americans aged
12 and older misused opioids, including 9.9
million prescription pain reliever abusers and
808,000 heroin users
>70,200 overdose deaths in
the United States and 47,600
of those overdose deaths
involved opioids
19% of US population
received one or more
opioid prescriptions
Prescription opioid volumes peaked,
with the equivalent of 240 billion
milligrams of morphine prescribed,
according to the market research firm,
IQVIA Institute for Human Data
Science
>52,000 people died of drug
overdoses, nearly two-thirds of
which were linked to opioids
like Percocet, OxyContin,
heroin, and fentanyl
US physicians wrote 259 million
prescriptions for opioid painkillers —
enough to give a bottle of pills to every
adult in the country
4
Opioid Epidemic: America’s Worst Drug Crisis Ever (2/2)
▪ Drug overdoses now kill more people than gun homicides and
car crashes combined
▪ 57.8 – Highest deaths per 100,000 individuals in the state of
West Virginia
▪ Between 2007 and 2016, the most widely prescribed opioid
was hydrocodone (Vicodin)
▪ In 2016, 6.2 billion hydrocodone pills were distributed
nationwide
5
Opioid Epidemic: Key Driving Factors
Creation of “Pill-Mills”
▪ Massive marketing by drug manufacturers about effectiveness & safety of opioid drugs
▪ Uncontrolled prescriptions by physicians to improve patient satisfaction & profit margins
Growth in Instances of Chronic Pain
▪ Continuous growth in patients with chronic pain – about 50mn suffer from chronic pain, with
20mn having high-impact chronic pain
▪ Opioids are the easiest, economical and readily available means to reduce the pain
▪ Alternate therapies are expensive & mostly not covered under benefit plan
Easy Access to Opioids
▪ For many years, there was neither legislation nor any kind of monitoring on consumption of
prescription drugs
▪ Easy availability of illicit drugs such as Heroin acts as substitute for opioids
Socio-economic Causes
▪ The rate of opioid mortality is found to be higher in areas with higher poverty, unemployment,
disability, single parent families, and divorce/separation
▪ Major section of population under the abuse of legally available opioids are found to be middle-
aged women (over 40 years)
6
Opioid Epidemic: Multi-Dimensional Impact
Growing mortality rate
▪ Leading cause of death – Deaths due to opioids are 1.5 times the deaths caused due to road
accidents
Economic Burden
▪ Opioid Epidemics’ estimated cost to the nation in 2017: $78 Bn
Loss in Productivity
▪ Highest rate of opioid overdoses in population in age range 25 – 54 years
Burden on high cost settings
▪ The rate of ER visits for opioid overdose cases has grown to 45% in 45 states in 2017
Pre-natal effects
▪ Around 75 – 90% of the prenatal opioid–exposed infants are diagnosed with Neonatal Abstinence
Syndrome
Family crises
▪ A large section of victims are middle-aged females leading to massive disruptions in family lives
7
Opioid Epidemic: Measures to Fight the Epidemic (1/2)
Litigations against drug
manufacturers &
distributors
▪ Multiple lawsuits across states against Pharma companies for fueling the crisis by
misleading data and unethical marketing practices
▪ Key defendants include Pharma giants such as J&J, Purdue Pharma, Amerisource
Bergen, McKesson Corp, Cardinal Health, etc.
▪ Purdue pharma has 2,000+ opioid lawsuits totaling to around $12 billion in
compensation
New regulations for
managing OUD (Opioid Use
Disorder)
▪ A Prescription Drug Monitoring Program (PDMP) is a statewide electronic
database to track all controlled substance prescriptions
• Data available to authorized users – medical professionals, regulatory
bodies, public health agencies, etc.
• 49 states currently participate in this program
▪ Medication Assisted Treatment (MAT) is a statewide program for rehabilitation
of OUD patients
• A combination of antidotes such as Methadone, Buprenorphine &
Naltrexone along with focus on behavioral health
• Only 22 states have currently implemented this program
▪ Modification in MIPS program – removal of Pain Management Questions from
HCAHPS survey
8
Opioid Epidemic: Measures to Fight the Epidemic (2/2)
Preventive Care
▪ Increase proportion of providers using evidence-based guidelines while prescribing
opioids
▪ Develop additional tools for patients as well as care givers for using opioids
appropriately
▪ Provide timely and accurate notifications to curb overuse of opioids
▪ Modify the benefit plans to have prior authorizations/referrals for opioids
▪ Population Health Management programs to manage high risk patients
Research &
Educational Programs
▪ HHS has a 5-point strategy to fight opioid crisis which includes:
• Better research
• Improved pain management
• Availability of overdose reversing drugs
• Timely reporting of overdose data
• Better services for prevention and recovery
▪ CDC created a Strategic Framework for the opioid crisis which includes:
• Campaigns to create awareness for negative impact of opioids
• Building public health advisories to empower local communities in the fight
against opioids
• Evidence-based community level intervention programs
• Surveillance programs to improve prevention
9
Opioid Epidemic: What Lies in the Future
Immediate Impact
▪ Latest reports from CMS
indicate no decline of the
opioid epidemic despite
the efforts
▪ Industry observers agree
that the rates of addiction,
overdose, and death is
likely to get worse in the
coming years before they
start improving
Ecosystem Approach
▪ An ecosystem approach
could become the best
hope in the battle against
opioid addiction
▪ Regulatory bodies and
state governments will
need to work with
providers, payers, local
agencies, law enforcement
bodies, community groups,
and individual citizens for
an optimum solution
Evidence-based Measures
▪ Stakeholders need to
develop & implement
mitigation plans that are
data driven in nature &
and responsive to
emerging trends in the
epidemic as well as best
practices
▪ Few health plans,
providers, and pharmacy
benefit managers are
taking a data driven,
evidence-based approach
to help change patient and
physician behavior
▪ There is a need for a
cutting age technology to
support these to ensure
the success of such
endeavors
10
Opioid Epidemic: A Step by CMS in the Right Direction
Prevention
Significant progress has been
made in identifying
inappropriate prescribing
pattern
Treatment
Medicare, Medicaid, and
private health plans provide
some coverage for pain and
opioid use disorder treatment
Care
Data provides insights into
doctor, pharmacy, and patient
use of prescription opioids and
effectiveness of treatment
1. Identify and stop
inappropriate prescribing of
opioids
2. Enhance diagnosis of OUD to
get people the support they
need earlier
3. Promote effective, non-
opioid pain treatments
1. Ensure access to treatment
across CMS programs and
geography
2. Give patients options for
broader range of treatments
3. Support innovation through
new models and best
practices
1. Understand opioid use
patterns across populations
2. Promote sharing of
actionable data across the
continuum of care
3. Monitor trends to assess
impact of prevention and
treatment efforts
CMS can build on these efforts to further:
CMS has published a roadmap outlining its efforts to address this issue of national concern
11
Key Considerations
1. Control Cost
2. Maintain High Quality of Care
3. Access to Patient Data
4. Continuous Engagement
5. Timely Interventions
Key Enablers
1. Virtual Care
2. Remote Patient Monitoring
3. Advanced Analytics
4. AI / ML
5. Natural Language Processing (NLP)
6. Digital Therapeutics
7. Internet of Things (IoT)
Opioid Epidemic: Role of Technology
Healthcare facilities need to leverage technology and tools to address prescription opioid misuse and
abuse.
12
Opioid Epidemic: Potential Areas for Technology Vendors
Opioid Registries
Create a longitudinal view of OUD patient by integrating data across
multiple sources & formats – clinical, claims, SCM, social history, etc.
Regulatory Compliance
Leverage BI / Analytics and Reporting services for assisting providers with
regulatory needs – MAT program, MIPS/MACRA, etc.
Advanced Analytics
Implement multiple Population Health use cases – creating patient
cohorts, identifying high risk patients, physician prescription patterns,
biomarkers for pain severity, etc.
NLP
Leverage cognitive technologies in NLP to read unstructured data residing
in clinical notes, etc. & convert these into usable format
Mobile-based Apps
Build mobile apps for OUD patients – medication adherence, medication
impact & outcomes as well as for physicians – alerts and notifications
during an adverse event, etc.
Opioid-based KPIs
Determine key domains for reporting – prevention, pain management,
oud treatment outcomes, etc. and metrics under each for performance
evaluation
13
References
▪ https://www2.deloitte.com/content/dam/insights/us/articles/fighting-opioid-crisis-heroin-abuse-ecosystem-
approach/DUP_3406_Opioid-ecosystem_MASTER_FINAL.pdf
▪ https://www2.deloitte.com/content/dam/insights/us/articles/4392_Health-plan-strategy-Opioid-
crisis/DI_Health-plan-strategy-Opioid-crisis.pdf
▪ https://www.pwc.com/us/en/industries/health-industries/top-health-industry-issues/opioid-crisis.html
▪ https://www.healthcareitnews.com/news/opioid-epidemic-why-arent-prescription-drug-monitoring-programs-
more-effective
▪ https://www.modernhealthcare.com/article/20180619/TRANSFORMATION01/180619893/mat-underutilized-
by-hospitals-in-treating-opioid-addiction
▪ https://medium.com/wagovernor/what-are-hubs-and-spokes-and-how-can-they-help-fight-the-opioid-
epidemic-d65f4f20345f
▪ https://www.healthcareitnews.com/video/tech-and-innovation-bring-hope-combating-devastating-opioid-
crisis?mkt_tok=eyJpIjoiTVRSa01qWmxPVFV5TlRSbSIsInQiOiJ5YzBxUFR6VjVcLzRUb3hJQ1BlTkFHeWV0V2paZ2Ny
NEZhdFJnZjR2V2o1akVYT2hlT2NMSG1LSWgzS1wvc0FDVE9pa28rVGdXdm53TlhCd0YwY3NXeWJ6TUgzb0lZalNO
WWlzQ25EcTZlcUhPNmpla1wvNVVIN3F3VTFVOGVZYWRhNSJ9
▪ https://www.healthcareitnews.com/news/clinicians-need-better-opioid-data-within-their-workflows-says-
ehra?mkt_tok=eyJpIjoiTkROa1pqQmlZelpsTlRZeSIsInQiOiJpdnAxU3d1OGtmeXhBOW12QXM2MHdobVFuSzBDe
lJzcjVhUXgwbWYraTEwbktZcFFxXC9KbVZPcVBydXdoUG1nbXc3bFwvNnZHUTliaGJaNlNjRUFKaWJiSlJJTnh1Vk13O
GU2MlpiejhQSVVwV051MW5Kb3ozOU5ldEhZRXFuNThDIn0%3D
▪ https://edition.cnn.com/2017/09/18/health/opioid-crisis-fast-facts/index.html
▪ https://www.vox.com/science-and-health/2017/3/23/14987892/opioid-heroin-epidemic-charts
About CitiusTech
4,000+
Healthcare IT professionals worldwide
1,500+
Healthcare software engineering
400+
FHIR / HL7 certified professionals
25%+
CAGR over last 5 years
110+
Healthcare customers
▪ Healthcare technology companies
▪ Hospitals, IDNs & medical groups
▪ Payers and health plans
▪ ACO, MCO, HIE, HIX, NHIN and RHIO
▪ Pharma & Life Sciences companies
14
Thank You
Author:
Shiven Kalelkar
Sr. Healthcare Consultant
thoughtleaders@citiustech.com

More Related Content

What's hot

Medication Safety
Medication SafetyMedication Safety
Medication Safety
rmullenger
 
Reporting of pharmacovigilance and role of pharmacist
Reporting of pharmacovigilance and role of pharmacistReporting of pharmacovigilance and role of pharmacist
Reporting of pharmacovigilance and role of pharmacist
Dr. Ramesh Bhandari
 
Rational use of Antibiotics
Rational use of AntibioticsRational use of Antibiotics
Rational use of Antibiotics
Engr. Md. Raihan Hossain
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology
ABUBAKRANSARI2
 
Medication errors
Medication errorsMedication errors
Medication errors
Dr.Irfan shaikh
 
Clinical pharmacy
Clinical pharmacyClinical pharmacy
Clinical pharmacy
Mohammed Mohammed
 
PHARMACOEPIDEMIOLOGY
PHARMACOEPIDEMIOLOGYPHARMACOEPIDEMIOLOGY
PHARMACOEPIDEMIOLOGY
AISHASID
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
Divjyot Kaur
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
Jannatul Ferdoush
 
Pharmacoeconomics1
Pharmacoeconomics1Pharmacoeconomics1
Pharmacoeconomics1jinender16
 
Medication errors and safety
Medication errors and safetyMedication errors and safety
Medication errors and safety
O0793347636M
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
Dr. Siddhartha Dutta
 
Estimating drug requirements
Estimating drug requirementsEstimating drug requirements
Estimating drug requirements
Mona Saleh Abd El Salam
 
Hospital pharmacy management
Hospital pharmacy managementHospital pharmacy management
Hospital pharmacy management
Armin Eisazaei
 
Pharmacy Practice: Managing Formularies
Pharmacy Practice: Managing FormulariesPharmacy Practice: Managing Formularies
Pharmacy Practice: Managing Formularies
Anas Bahnassi أنس البهنسي
 
Rational therapeutics
Rational therapeuticsRational therapeutics
Rational therapeutics
Mayur Chaudhari
 
Therapeutic drug monitoring- Descriptive questions and answers.docx
Therapeutic drug monitoring- Descriptive questions and answers.docxTherapeutic drug monitoring- Descriptive questions and answers.docx
Therapeutic drug monitoring- Descriptive questions and answers.docx
DipeshGamare
 
Hosptal pharmacy management
Hosptal pharmacy management Hosptal pharmacy management
Hosptal pharmacy management
Pravindas Vaishnav
 
Medication history
Medication historyMedication history
Medication history
Nursing Hi Nursing
 

What's hot (20)

Medication Safety
Medication SafetyMedication Safety
Medication Safety
 
Reporting of pharmacovigilance and role of pharmacist
Reporting of pharmacovigilance and role of pharmacistReporting of pharmacovigilance and role of pharmacist
Reporting of pharmacovigilance and role of pharmacist
 
Rational use of Antibiotics
Rational use of AntibioticsRational use of Antibiotics
Rational use of Antibiotics
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology
 
Medication errors
Medication errorsMedication errors
Medication errors
 
Clinical pharmacy
Clinical pharmacyClinical pharmacy
Clinical pharmacy
 
PHARMACOEPIDEMIOLOGY
PHARMACOEPIDEMIOLOGYPHARMACOEPIDEMIOLOGY
PHARMACOEPIDEMIOLOGY
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Pharmacoeconomics1
Pharmacoeconomics1Pharmacoeconomics1
Pharmacoeconomics1
 
Medication errors and safety
Medication errors and safetyMedication errors and safety
Medication errors and safety
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Estimating drug requirements
Estimating drug requirementsEstimating drug requirements
Estimating drug requirements
 
Hospital pharmacy management
Hospital pharmacy managementHospital pharmacy management
Hospital pharmacy management
 
Pharmacy Practice: Managing Formularies
Pharmacy Practice: Managing FormulariesPharmacy Practice: Managing Formularies
Pharmacy Practice: Managing Formularies
 
Dispensing medication errors
Dispensing medication errorsDispensing medication errors
Dispensing medication errors
 
Rational therapeutics
Rational therapeuticsRational therapeutics
Rational therapeutics
 
Therapeutic drug monitoring- Descriptive questions and answers.docx
Therapeutic drug monitoring- Descriptive questions and answers.docxTherapeutic drug monitoring- Descriptive questions and answers.docx
Therapeutic drug monitoring- Descriptive questions and answers.docx
 
Hosptal pharmacy management
Hosptal pharmacy management Hosptal pharmacy management
Hosptal pharmacy management
 
Medication history
Medication historyMedication history
Medication history
 

Similar to Opioid Epidemic - Causes, Impact and Future

Wed gs frieden
Wed gs friedenWed gs frieden
Wed gs frieden
OPUNITE
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
OPUNITE
 
Integration of health records in the prescription drug monitoring program
Integration of health records in the prescription drug monitoring programIntegration of health records in the prescription drug monitoring program
Integration of health records in the prescription drug monitoring program
AlayziaHarris
 
Obama care a new opportunity in us healthcare - finpro
Obama care   a new opportunity in us healthcare - finproObama care   a new opportunity in us healthcare - finpro
Obama care a new opportunity in us healthcare - finpro
Business Finland
 
Cms opioid-misuse-strategy-2016
Cms opioid-misuse-strategy-2016Cms opioid-misuse-strategy-2016
Cms opioid-misuse-strategy-2016
Paul Coelho, MD
 
ERs Face the Problem of Multiple Drugs in Overdose Patients
ERs Face the Problem of Multiple Drugs in Overdose PatientsERs Face the Problem of Multiple Drugs in Overdose Patients
ERs Face the Problem of Multiple Drugs in Overdose Patients
Medical Transcription Service Company
 
Drug Discovery, Development and Commercialization
Drug Discovery, Development and CommercializationDrug Discovery, Development and Commercialization
Drug Discovery, Development and Commercialization
Bashant Kumar sah
 
New study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribingNew study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribing
Δρ. Γιώργος K. Κασάπης
 
Pharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and IntelligencePharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and Intelligence
Beroe Inc - Advantage Procurement
 
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbellRx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
OPUNITE
 
substance-abuse-laws-capstone-presentation-2022.pptx
substance-abuse-laws-capstone-presentation-2022.pptxsubstance-abuse-laws-capstone-presentation-2022.pptx
substance-abuse-laws-capstone-presentation-2022.pptx
RoNyk2
 
Rx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezRx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendez
OPUNITE
 
Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)
Canadian Cancer Survivor Network
 
Health Exchange: Access to medicines April 2010
Health Exchange: Access to medicines April 2010Health Exchange: Access to medicines April 2010
Health Exchange: Access to medicines April 2010
HealthlinkWorldwide
 
Financing Healthcare (Part 2) Lecture C
Financing Healthcare (Part 2) Lecture CFinancing Healthcare (Part 2) Lecture C
Financing Healthcare (Part 2) Lecture C
CMDLearning
 
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
 
Patient centered Pharmacovigilance .. .
Patient centered Pharmacovigilance     .. .Patient centered Pharmacovigilance     .. .
Patient centered Pharmacovigilance .. .
ClinosolIndia
 
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalWed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
OPUNITE
 
HIV Treatment Access in Middle-Income Countries
HIV Treatment Access in Middle-Income CountriesHIV Treatment Access in Middle-Income Countries
HIV Treatment Access in Middle-Income Countries
MakeMedicinesAffordable
 
Tpp 1 walls abou_nader
Tpp 1 walls abou_naderTpp 1 walls abou_nader
Tpp 1 walls abou_nader
OPUNITE
 

Similar to Opioid Epidemic - Causes, Impact and Future (20)

Wed gs frieden
Wed gs friedenWed gs frieden
Wed gs frieden
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
 
Integration of health records in the prescription drug monitoring program
Integration of health records in the prescription drug monitoring programIntegration of health records in the prescription drug monitoring program
Integration of health records in the prescription drug monitoring program
 
Obama care a new opportunity in us healthcare - finpro
Obama care   a new opportunity in us healthcare - finproObama care   a new opportunity in us healthcare - finpro
Obama care a new opportunity in us healthcare - finpro
 
Cms opioid-misuse-strategy-2016
Cms opioid-misuse-strategy-2016Cms opioid-misuse-strategy-2016
Cms opioid-misuse-strategy-2016
 
ERs Face the Problem of Multiple Drugs in Overdose Patients
ERs Face the Problem of Multiple Drugs in Overdose PatientsERs Face the Problem of Multiple Drugs in Overdose Patients
ERs Face the Problem of Multiple Drugs in Overdose Patients
 
Drug Discovery, Development and Commercialization
Drug Discovery, Development and CommercializationDrug Discovery, Development and Commercialization
Drug Discovery, Development and Commercialization
 
New study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribingNew study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribing
 
Pharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and IntelligencePharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and Intelligence
 
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbellRx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
 
substance-abuse-laws-capstone-presentation-2022.pptx
substance-abuse-laws-capstone-presentation-2022.pptxsubstance-abuse-laws-capstone-presentation-2022.pptx
substance-abuse-laws-capstone-presentation-2022.pptx
 
Rx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezRx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendez
 
Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)
 
Health Exchange: Access to medicines April 2010
Health Exchange: Access to medicines April 2010Health Exchange: Access to medicines April 2010
Health Exchange: Access to medicines April 2010
 
Financing Healthcare (Part 2) Lecture C
Financing Healthcare (Part 2) Lecture CFinancing Healthcare (Part 2) Lecture C
Financing Healthcare (Part 2) Lecture C
 
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
 
Patient centered Pharmacovigilance .. .
Patient centered Pharmacovigilance     .. .Patient centered Pharmacovigilance     .. .
Patient centered Pharmacovigilance .. .
 
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalWed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
 
HIV Treatment Access in Middle-Income Countries
HIV Treatment Access in Middle-Income CountriesHIV Treatment Access in Middle-Income Countries
HIV Treatment Access in Middle-Income Countries
 
Tpp 1 walls abou_nader
Tpp 1 walls abou_naderTpp 1 walls abou_nader
Tpp 1 walls abou_nader
 

More from CitiusTech

Member Engagement Using Sentiment Analysis for Health Plans
Member Engagement Using Sentiment Analysis for Health PlansMember Engagement Using Sentiment Analysis for Health Plans
Member Engagement Using Sentiment Analysis for Health Plans
CitiusTech
 
Evolving Role of Digital Biomarkers in Healthcare
Evolving Role of Digital Biomarkers in HealthcareEvolving Role of Digital Biomarkers in Healthcare
Evolving Role of Digital Biomarkers in Healthcare
CitiusTech
 
Virtual Care: Key Challenges & Opportunities for Payer Organizations
Virtual Care: Key Challenges & Opportunities for Payer Organizations Virtual Care: Key Challenges & Opportunities for Payer Organizations
Virtual Care: Key Challenges & Opportunities for Payer Organizations
CitiusTech
 
Provider-led Health Plans (Payviders)
Provider-led Health Plans (Payviders)Provider-led Health Plans (Payviders)
Provider-led Health Plans (Payviders)
CitiusTech
 
CMS Medicare Advantage 2021 Star Ratings: An Analysis
CMS Medicare Advantage 2021 Star Ratings: An AnalysisCMS Medicare Advantage 2021 Star Ratings: An Analysis
CMS Medicare Advantage 2021 Star Ratings: An Analysis
CitiusTech
 
Accelerate Healthcare Technology Modernization with Containerization and DevOps
Accelerate Healthcare Technology Modernization with Containerization and DevOpsAccelerate Healthcare Technology Modernization with Containerization and DevOps
Accelerate Healthcare Technology Modernization with Containerization and DevOps
CitiusTech
 
FHIR for Life Sciences
FHIR for Life SciencesFHIR for Life Sciences
FHIR for Life Sciences
CitiusTech
 
Leveraging Analytics to Identify High Risk Patients
Leveraging Analytics to Identify High Risk PatientsLeveraging Analytics to Identify High Risk Patients
Leveraging Analytics to Identify High Risk Patients
CitiusTech
 
FHIR Adoption Framework for Payers
FHIR Adoption Framework for PayersFHIR Adoption Framework for Payers
FHIR Adoption Framework for Payers
CitiusTech
 
Payer-Provider Engagement
Payer-Provider Engagement Payer-Provider Engagement
Payer-Provider Engagement
CitiusTech
 
COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021
COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021
COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021
CitiusTech
 
Demystifying Robotic Process Automation (RPA) & Automation Testing
Demystifying Robotic Process Automation (RPA) & Automation TestingDemystifying Robotic Process Automation (RPA) & Automation Testing
Demystifying Robotic Process Automation (RPA) & Automation Testing
CitiusTech
 
Progressive Web Apps in Healthcare
Progressive Web Apps in HealthcareProgressive Web Apps in Healthcare
Progressive Web Apps in Healthcare
CitiusTech
 
RPA in Healthcare
RPA in HealthcareRPA in Healthcare
RPA in Healthcare
CitiusTech
 
6 Epilepsy Use Cases for NLP
6 Epilepsy Use Cases for NLP6 Epilepsy Use Cases for NLP
6 Epilepsy Use Cases for NLP
CitiusTech
 
Rising Importance of Health Economics & Outcomes Research
Rising Importance of Health Economics & Outcomes ResearchRising Importance of Health Economics & Outcomes Research
Rising Importance of Health Economics & Outcomes Research
CitiusTech
 
ICD 11: Impact on Payer Market
ICD 11: Impact on Payer MarketICD 11: Impact on Payer Market
ICD 11: Impact on Payer Market
CitiusTech
 
Testing Strategies for Data Lake Hosted on Hadoop
Testing Strategies for Data Lake Hosted on HadoopTesting Strategies for Data Lake Hosted on Hadoop
Testing Strategies for Data Lake Hosted on Hadoop
CitiusTech
 
Driving Home Health Efficiency through Data Analytics
Driving Home Health Efficiency through Data AnalyticsDriving Home Health Efficiency through Data Analytics
Driving Home Health Efficiency through Data Analytics
CitiusTech
 
Poster Presentation - FDA Compliance Landscape & What it Means to Your AI Asp...
Poster Presentation - FDA Compliance Landscape & What it Means to Your AI Asp...Poster Presentation - FDA Compliance Landscape & What it Means to Your AI Asp...
Poster Presentation - FDA Compliance Landscape & What it Means to Your AI Asp...
CitiusTech
 

More from CitiusTech (20)

Member Engagement Using Sentiment Analysis for Health Plans
Member Engagement Using Sentiment Analysis for Health PlansMember Engagement Using Sentiment Analysis for Health Plans
Member Engagement Using Sentiment Analysis for Health Plans
 
Evolving Role of Digital Biomarkers in Healthcare
Evolving Role of Digital Biomarkers in HealthcareEvolving Role of Digital Biomarkers in Healthcare
Evolving Role of Digital Biomarkers in Healthcare
 
Virtual Care: Key Challenges & Opportunities for Payer Organizations
Virtual Care: Key Challenges & Opportunities for Payer Organizations Virtual Care: Key Challenges & Opportunities for Payer Organizations
Virtual Care: Key Challenges & Opportunities for Payer Organizations
 
Provider-led Health Plans (Payviders)
Provider-led Health Plans (Payviders)Provider-led Health Plans (Payviders)
Provider-led Health Plans (Payviders)
 
CMS Medicare Advantage 2021 Star Ratings: An Analysis
CMS Medicare Advantage 2021 Star Ratings: An AnalysisCMS Medicare Advantage 2021 Star Ratings: An Analysis
CMS Medicare Advantage 2021 Star Ratings: An Analysis
 
Accelerate Healthcare Technology Modernization with Containerization and DevOps
Accelerate Healthcare Technology Modernization with Containerization and DevOpsAccelerate Healthcare Technology Modernization with Containerization and DevOps
Accelerate Healthcare Technology Modernization with Containerization and DevOps
 
FHIR for Life Sciences
FHIR for Life SciencesFHIR for Life Sciences
FHIR for Life Sciences
 
Leveraging Analytics to Identify High Risk Patients
Leveraging Analytics to Identify High Risk PatientsLeveraging Analytics to Identify High Risk Patients
Leveraging Analytics to Identify High Risk Patients
 
FHIR Adoption Framework for Payers
FHIR Adoption Framework for PayersFHIR Adoption Framework for Payers
FHIR Adoption Framework for Payers
 
Payer-Provider Engagement
Payer-Provider Engagement Payer-Provider Engagement
Payer-Provider Engagement
 
COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021
COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021
COVID19: Impact & Mitigation Strategies for Payer Quality Improvement 2021
 
Demystifying Robotic Process Automation (RPA) & Automation Testing
Demystifying Robotic Process Automation (RPA) & Automation TestingDemystifying Robotic Process Automation (RPA) & Automation Testing
Demystifying Robotic Process Automation (RPA) & Automation Testing
 
Progressive Web Apps in Healthcare
Progressive Web Apps in HealthcareProgressive Web Apps in Healthcare
Progressive Web Apps in Healthcare
 
RPA in Healthcare
RPA in HealthcareRPA in Healthcare
RPA in Healthcare
 
6 Epilepsy Use Cases for NLP
6 Epilepsy Use Cases for NLP6 Epilepsy Use Cases for NLP
6 Epilepsy Use Cases for NLP
 
Rising Importance of Health Economics & Outcomes Research
Rising Importance of Health Economics & Outcomes ResearchRising Importance of Health Economics & Outcomes Research
Rising Importance of Health Economics & Outcomes Research
 
ICD 11: Impact on Payer Market
ICD 11: Impact on Payer MarketICD 11: Impact on Payer Market
ICD 11: Impact on Payer Market
 
Testing Strategies for Data Lake Hosted on Hadoop
Testing Strategies for Data Lake Hosted on HadoopTesting Strategies for Data Lake Hosted on Hadoop
Testing Strategies for Data Lake Hosted on Hadoop
 
Driving Home Health Efficiency through Data Analytics
Driving Home Health Efficiency through Data AnalyticsDriving Home Health Efficiency through Data Analytics
Driving Home Health Efficiency through Data Analytics
 
Poster Presentation - FDA Compliance Landscape & What it Means to Your AI Asp...
Poster Presentation - FDA Compliance Landscape & What it Means to Your AI Asp...Poster Presentation - FDA Compliance Landscape & What it Means to Your AI Asp...
Poster Presentation - FDA Compliance Landscape & What it Means to Your AI Asp...
 

Recently uploaded

Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
Thijs Feryn
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
ThousandEyes
 
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Jeffrey Haguewood
 
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Thierry Lestable
 
DevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA ConnectDevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA Connect
Kari Kakkonen
 
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdfFIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance
 
PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
ControlCase
 
The Future of Platform Engineering
The Future of Platform EngineeringThe Future of Platform Engineering
The Future of Platform Engineering
Jemma Hussein Allen
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance
 
Essentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with ParametersEssentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with Parameters
Safe Software
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
Laura Byrne
 
Epistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI supportEpistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI support
Alan Dix
 
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdfFIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance
 
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance
 
Generating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using SmithyGenerating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using Smithy
g2nightmarescribd
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
Guy Korland
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
BookNet Canada
 
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
Product School
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
Product School
 
Leading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdfLeading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdf
OnBoard
 

Recently uploaded (20)

Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
 
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
 
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
 
DevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA ConnectDevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA Connect
 
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdfFIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
 
PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
 
The Future of Platform Engineering
The Future of Platform EngineeringThe Future of Platform Engineering
The Future of Platform Engineering
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
 
Essentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with ParametersEssentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with Parameters
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
 
Epistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI supportEpistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI support
 
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdfFIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
 
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
 
Generating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using SmithyGenerating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using Smithy
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
 
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
 
Leading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdfLeading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdf
 

Opioid Epidemic - Causes, Impact and Future

  • 1. This document is confidential and contains proprietary information, including trade secrets of CitiusTech. Neither the document nor any of the information contained in it may be reproduced or disclosed to any unauthorized person under any circumstances without the express written permission of CitiusTech. Opioid Epidemic: Causes, Impact & Future January 2020| Author: Shiven Kalelkar; Sr. Healthcare Consultant CitiusTech Thought Leadership
  • 2. 2 Agenda ▪ Opioid Epidemic: Key Trends ▪ Opioid Epidemic: Measures for Controlling the Epidemic ▪ Opioid Epidemic: What Lies in the Future ▪ References
  • 3. 3 Opioid Epidemic: America’s Worst Drug Crisis Ever (1/2) 2011 2012 2015 2016 2017 2018 An estimated 10.3 million Americans aged 12 and older misused opioids, including 9.9 million prescription pain reliever abusers and 808,000 heroin users >70,200 overdose deaths in the United States and 47,600 of those overdose deaths involved opioids 19% of US population received one or more opioid prescriptions Prescription opioid volumes peaked, with the equivalent of 240 billion milligrams of morphine prescribed, according to the market research firm, IQVIA Institute for Human Data Science >52,000 people died of drug overdoses, nearly two-thirds of which were linked to opioids like Percocet, OxyContin, heroin, and fentanyl US physicians wrote 259 million prescriptions for opioid painkillers — enough to give a bottle of pills to every adult in the country
  • 4. 4 Opioid Epidemic: America’s Worst Drug Crisis Ever (2/2) ▪ Drug overdoses now kill more people than gun homicides and car crashes combined ▪ 57.8 – Highest deaths per 100,000 individuals in the state of West Virginia ▪ Between 2007 and 2016, the most widely prescribed opioid was hydrocodone (Vicodin) ▪ In 2016, 6.2 billion hydrocodone pills were distributed nationwide
  • 5. 5 Opioid Epidemic: Key Driving Factors Creation of “Pill-Mills” ▪ Massive marketing by drug manufacturers about effectiveness & safety of opioid drugs ▪ Uncontrolled prescriptions by physicians to improve patient satisfaction & profit margins Growth in Instances of Chronic Pain ▪ Continuous growth in patients with chronic pain – about 50mn suffer from chronic pain, with 20mn having high-impact chronic pain ▪ Opioids are the easiest, economical and readily available means to reduce the pain ▪ Alternate therapies are expensive & mostly not covered under benefit plan Easy Access to Opioids ▪ For many years, there was neither legislation nor any kind of monitoring on consumption of prescription drugs ▪ Easy availability of illicit drugs such as Heroin acts as substitute for opioids Socio-economic Causes ▪ The rate of opioid mortality is found to be higher in areas with higher poverty, unemployment, disability, single parent families, and divorce/separation ▪ Major section of population under the abuse of legally available opioids are found to be middle- aged women (over 40 years)
  • 6. 6 Opioid Epidemic: Multi-Dimensional Impact Growing mortality rate ▪ Leading cause of death – Deaths due to opioids are 1.5 times the deaths caused due to road accidents Economic Burden ▪ Opioid Epidemics’ estimated cost to the nation in 2017: $78 Bn Loss in Productivity ▪ Highest rate of opioid overdoses in population in age range 25 – 54 years Burden on high cost settings ▪ The rate of ER visits for opioid overdose cases has grown to 45% in 45 states in 2017 Pre-natal effects ▪ Around 75 – 90% of the prenatal opioid–exposed infants are diagnosed with Neonatal Abstinence Syndrome Family crises ▪ A large section of victims are middle-aged females leading to massive disruptions in family lives
  • 7. 7 Opioid Epidemic: Measures to Fight the Epidemic (1/2) Litigations against drug manufacturers & distributors ▪ Multiple lawsuits across states against Pharma companies for fueling the crisis by misleading data and unethical marketing practices ▪ Key defendants include Pharma giants such as J&J, Purdue Pharma, Amerisource Bergen, McKesson Corp, Cardinal Health, etc. ▪ Purdue pharma has 2,000+ opioid lawsuits totaling to around $12 billion in compensation New regulations for managing OUD (Opioid Use Disorder) ▪ A Prescription Drug Monitoring Program (PDMP) is a statewide electronic database to track all controlled substance prescriptions • Data available to authorized users – medical professionals, regulatory bodies, public health agencies, etc. • 49 states currently participate in this program ▪ Medication Assisted Treatment (MAT) is a statewide program for rehabilitation of OUD patients • A combination of antidotes such as Methadone, Buprenorphine & Naltrexone along with focus on behavioral health • Only 22 states have currently implemented this program ▪ Modification in MIPS program – removal of Pain Management Questions from HCAHPS survey
  • 8. 8 Opioid Epidemic: Measures to Fight the Epidemic (2/2) Preventive Care ▪ Increase proportion of providers using evidence-based guidelines while prescribing opioids ▪ Develop additional tools for patients as well as care givers for using opioids appropriately ▪ Provide timely and accurate notifications to curb overuse of opioids ▪ Modify the benefit plans to have prior authorizations/referrals for opioids ▪ Population Health Management programs to manage high risk patients Research & Educational Programs ▪ HHS has a 5-point strategy to fight opioid crisis which includes: • Better research • Improved pain management • Availability of overdose reversing drugs • Timely reporting of overdose data • Better services for prevention and recovery ▪ CDC created a Strategic Framework for the opioid crisis which includes: • Campaigns to create awareness for negative impact of opioids • Building public health advisories to empower local communities in the fight against opioids • Evidence-based community level intervention programs • Surveillance programs to improve prevention
  • 9. 9 Opioid Epidemic: What Lies in the Future Immediate Impact ▪ Latest reports from CMS indicate no decline of the opioid epidemic despite the efforts ▪ Industry observers agree that the rates of addiction, overdose, and death is likely to get worse in the coming years before they start improving Ecosystem Approach ▪ An ecosystem approach could become the best hope in the battle against opioid addiction ▪ Regulatory bodies and state governments will need to work with providers, payers, local agencies, law enforcement bodies, community groups, and individual citizens for an optimum solution Evidence-based Measures ▪ Stakeholders need to develop & implement mitigation plans that are data driven in nature & and responsive to emerging trends in the epidemic as well as best practices ▪ Few health plans, providers, and pharmacy benefit managers are taking a data driven, evidence-based approach to help change patient and physician behavior ▪ There is a need for a cutting age technology to support these to ensure the success of such endeavors
  • 10. 10 Opioid Epidemic: A Step by CMS in the Right Direction Prevention Significant progress has been made in identifying inappropriate prescribing pattern Treatment Medicare, Medicaid, and private health plans provide some coverage for pain and opioid use disorder treatment Care Data provides insights into doctor, pharmacy, and patient use of prescription opioids and effectiveness of treatment 1. Identify and stop inappropriate prescribing of opioids 2. Enhance diagnosis of OUD to get people the support they need earlier 3. Promote effective, non- opioid pain treatments 1. Ensure access to treatment across CMS programs and geography 2. Give patients options for broader range of treatments 3. Support innovation through new models and best practices 1. Understand opioid use patterns across populations 2. Promote sharing of actionable data across the continuum of care 3. Monitor trends to assess impact of prevention and treatment efforts CMS can build on these efforts to further: CMS has published a roadmap outlining its efforts to address this issue of national concern
  • 11. 11 Key Considerations 1. Control Cost 2. Maintain High Quality of Care 3. Access to Patient Data 4. Continuous Engagement 5. Timely Interventions Key Enablers 1. Virtual Care 2. Remote Patient Monitoring 3. Advanced Analytics 4. AI / ML 5. Natural Language Processing (NLP) 6. Digital Therapeutics 7. Internet of Things (IoT) Opioid Epidemic: Role of Technology Healthcare facilities need to leverage technology and tools to address prescription opioid misuse and abuse.
  • 12. 12 Opioid Epidemic: Potential Areas for Technology Vendors Opioid Registries Create a longitudinal view of OUD patient by integrating data across multiple sources & formats – clinical, claims, SCM, social history, etc. Regulatory Compliance Leverage BI / Analytics and Reporting services for assisting providers with regulatory needs – MAT program, MIPS/MACRA, etc. Advanced Analytics Implement multiple Population Health use cases – creating patient cohorts, identifying high risk patients, physician prescription patterns, biomarkers for pain severity, etc. NLP Leverage cognitive technologies in NLP to read unstructured data residing in clinical notes, etc. & convert these into usable format Mobile-based Apps Build mobile apps for OUD patients – medication adherence, medication impact & outcomes as well as for physicians – alerts and notifications during an adverse event, etc. Opioid-based KPIs Determine key domains for reporting – prevention, pain management, oud treatment outcomes, etc. and metrics under each for performance evaluation
  • 13. 13 References ▪ https://www2.deloitte.com/content/dam/insights/us/articles/fighting-opioid-crisis-heroin-abuse-ecosystem- approach/DUP_3406_Opioid-ecosystem_MASTER_FINAL.pdf ▪ https://www2.deloitte.com/content/dam/insights/us/articles/4392_Health-plan-strategy-Opioid- crisis/DI_Health-plan-strategy-Opioid-crisis.pdf ▪ https://www.pwc.com/us/en/industries/health-industries/top-health-industry-issues/opioid-crisis.html ▪ https://www.healthcareitnews.com/news/opioid-epidemic-why-arent-prescription-drug-monitoring-programs- more-effective ▪ https://www.modernhealthcare.com/article/20180619/TRANSFORMATION01/180619893/mat-underutilized- by-hospitals-in-treating-opioid-addiction ▪ https://medium.com/wagovernor/what-are-hubs-and-spokes-and-how-can-they-help-fight-the-opioid- epidemic-d65f4f20345f ▪ https://www.healthcareitnews.com/video/tech-and-innovation-bring-hope-combating-devastating-opioid- crisis?mkt_tok=eyJpIjoiTVRSa01qWmxPVFV5TlRSbSIsInQiOiJ5YzBxUFR6VjVcLzRUb3hJQ1BlTkFHeWV0V2paZ2Ny NEZhdFJnZjR2V2o1akVYT2hlT2NMSG1LSWgzS1wvc0FDVE9pa28rVGdXdm53TlhCd0YwY3NXeWJ6TUgzb0lZalNO WWlzQ25EcTZlcUhPNmpla1wvNVVIN3F3VTFVOGVZYWRhNSJ9 ▪ https://www.healthcareitnews.com/news/clinicians-need-better-opioid-data-within-their-workflows-says- ehra?mkt_tok=eyJpIjoiTkROa1pqQmlZelpsTlRZeSIsInQiOiJpdnAxU3d1OGtmeXhBOW12QXM2MHdobVFuSzBDe lJzcjVhUXgwbWYraTEwbktZcFFxXC9KbVZPcVBydXdoUG1nbXc3bFwvNnZHUTliaGJaNlNjRUFKaWJiSlJJTnh1Vk13O GU2MlpiejhQSVVwV051MW5Kb3ozOU5ldEhZRXFuNThDIn0%3D ▪ https://edition.cnn.com/2017/09/18/health/opioid-crisis-fast-facts/index.html ▪ https://www.vox.com/science-and-health/2017/3/23/14987892/opioid-heroin-epidemic-charts
  • 14. About CitiusTech 4,000+ Healthcare IT professionals worldwide 1,500+ Healthcare software engineering 400+ FHIR / HL7 certified professionals 25%+ CAGR over last 5 years 110+ Healthcare customers ▪ Healthcare technology companies ▪ Hospitals, IDNs & medical groups ▪ Payers and health plans ▪ ACO, MCO, HIE, HIX, NHIN and RHIO ▪ Pharma & Life Sciences companies 14 Thank You Author: Shiven Kalelkar Sr. Healthcare Consultant thoughtleaders@citiustech.com